OSTO:BIOEX (Sweden)
Â
Unit (2 Ordinary share & 1 Wrt)
kr
2.03
+0.010 (+0.5%)
Aug 21
Business Description
Bioextrax AB
ISIN : SE0016276752
Share Class Description:
OSTO:BIOEX: Unit (2 Ordinary share & 1 Wrt)Total Employee Number:
25Compare
Compare
Traded in other countries / regions
BIOEX.Sweden85X0.Germany IPO Date
2022-11-29Description
Bioextrax AB is engaged in the development and production of bio-plastics granules, organic hydrolyzed protein, and keratin fibers.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.89 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 26.12 | |||||
Beneish M-Score | -2.82 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.2 | |||||
3-Year EBITDA Growth Rate | 26.7 | |||||
3-Year EPS without NRI Growth Rate | 25.4 | |||||
3-Year FCF Growth Rate | 22.6 | |||||
3-Year Book Growth Rate | -24.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 20.03 | |||||
9-Day RSI | 28.73 | |||||
14-Day RSI | 33.87 | |||||
3-1 Month Momentum % | -2.3 | |||||
6-1 Month Momentum % | -16.39 | |||||
12-1 Month Momentum % | -28.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.32 | |||||
Quick Ratio | 6.32 | |||||
Cash Ratio | 5.47 | |||||
Days Sales Outstanding | 42.44 | |||||
Days Payable | 200.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.9 | |||||
Shareholder Yield % | -0.35 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -34.07 | |||||
Operating Margin % | -2106.37 | |||||
Net Margin % | -2091.19 | |||||
EBITDA Margin % | -1964.31 | |||||
FCF Margin % | -1539.28 | |||||
OCF Margin % | -1533.95 | |||||
ROE % | -98.3 | |||||
ROA % | -87.03 | |||||
ROIC % | -160.13 | |||||
3-Year ROIIC % | 7.22 | |||||
ROC (Joel Greenblatt) % | -296.99 | |||||
ROCE % | -98.3 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 96.67 | |||||
PB Ratio | 5.72 | |||||
Price-to-Tangible-Book | 5.64 | |||||
EV-to-EBIT | -4.71 | |||||
EV-to-EBITDA | -5.02 | |||||
EV-to-Revenue | 98.58 | |||||
EV-to-FCF | -6.4 | |||||
Price-to-GF-Value | 1.1 | |||||
| Price-to-Net-Current-Asset-Value | 8.46 | |||||
| Price-to-Net-Cash | 10.15 | |||||
Earnings Yield (Greenblatt) % | -21.23 | |||||
FCF Yield % | -13.75 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bioextrax AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 0.863 | ||
| EPS (TTM) (kr) | -0.438 | ||
| Beta | 0.3859 | ||
| 3-Year Sharpe Ratio | -0.21 | ||
| 3-Year Sortino Ratio | -0.32 | ||
| Volatility % | 58.29 | ||
| 14-Day RSI | 33.87 | ||
| 14-Day ATR (kr) | 0.222415 | ||
| 20-Day SMA (kr) | 2.399 | ||
| 12-1 Month Momentum % | -28.82 | ||
| 52-Week Range (kr) | 1.6 - 3.980676 | ||
| Shares Outstanding (Mil) | 47.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bioextrax AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bioextrax AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-18 | In 178 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-18 | In 178 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-19 | In 87 days | ||
| Third quarter earnings results for 2026 | 2026-11-19 | In 87 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-20 08:00 | 2.41 (-0.41%) | ||
| Second quarter earnings results for 2026 | 2026-08-20 | 2.41 (-0.41%) | ||
| First quarter earnings conference call for 2026 | 2026-05-22 11:00 | 2.61 (-5.43%) | ||
| First quarter earnings results for 2026 | 2026-05-22 | 2.61 (-5.43%) | ||
| General meeting for 2025 | 2026-05-21 10:00 | 2.78 (+6.92%) | ||
| Annual report for 2025 | 2026-04-20 | 2.57 (-2.28%) |
Show
Entries
Bioextrax AB Frequently Asked Questions
What is Bioextrax AB(OSTO:BIOEX)'s stock price today?
The current price of OSTO:BIOEX is kr2.03. The 52 week high of OSTO:BIOEX is kr3.98 and 52 week low is kr1.60.
When is next earnings date of Bioextrax AB(OSTO:BIOEX)?
The next earnings date of Bioextrax AB(OSTO:BIOEX) is 2026-11-19.
Does Bioextrax AB(OSTO:BIOEX) pay dividends? If so, how much?
Bioextrax AB(OSTO:BIOEX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Bioextrax AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers